Investigate Oral Zinc as a Prophylactic Treatment for Those at Risk for COVID-19

Am J Ophthalmol. 2020 Aug;216:A5-A6. doi: 10.1016/j.ajo.2020.04.028. Epub 2020 May 26.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Angiotensin-Converting Enzyme 2
  • Antiviral Agents / administration & dosage
  • Betacoronavirus / drug effects*
  • COVID-19
  • Clinical Trials as Topic
  • Coronavirus Infections / prevention & control*
  • Enzyme Inhibitors / administration & dosage
  • Humans
  • Pandemics / prevention & control*
  • Peptidyl-Dipeptidase A / drug effects
  • Pneumonia, Viral / prevention & control*
  • SARS-CoV-2
  • Zinc Compounds / administration & dosage*

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • Zinc Compounds
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2